Antibiotic Susceptibility Testing: Methods, Applications, and Clinical Relevance

Abstract

Antibiotic susceptibility testing (AST) is a critical laboratory procedure that guides the selection of appropriate antimicrobial therapy, informs infection control measures, and supports surveillance of antimicrobial resistance (AMR). The emergence of multidrug-resistant organisms has intensified the need for accurate, rapid, and reproducible AST methods. This methodological review provides a comprehensive overview of AST techniques, including traditional culture-based methods (disk diffusion, broth dilution, agar dilution, and E-test), automated systems, and emerging molecular and microfluidic approaches. We discuss standardization, interpretation guidelines, quality control, clinical applications, and limitations of each method. Understanding the principles and practical considerations of AST is essential for optimizing patient care and combating the global threat of AMR.

Introduction

The rise of antimicrobial resistance (AMR) represents a major public health concern worldwide. Misuse and overuse of antibiotics in clinical and agricultural settings have accelerated the evolution of resistant pathogens, leading to treatment failures, prolonged hospital stays, increased healthcare costs, and higher mortality rates. Accurate determination of the susceptibility of bacterial isolates to antibiotics is therefore essential for effective patient management and for guiding public health interventions.

Antibiotic susceptibility testing (AST) provides quantitative or qualitative data on the responsiveness of pathogens to antimicrobial agents. The results guide the choice of therapy, help in monitoring resistance trends, and support research on novel antimicrobial agents. AST encompasses a variety of methodologies, ranging from traditional phenotypic techniques to modern molecular and automated platforms, each with unique advantages and limitations.

This article aims to present a comprehensive methodological overview of AST, including classical, automated, and innovative techniques. We will discuss the principles, procedures, interpretation criteria, clinical relevance, quality control measures, and emerging trends in the field.

Principles of Antibiotic Susceptibility Testing

AST relies on exposing bacterial isolates to antimicrobial agents and assessing their ability to inhibit or kill the microorganisms. The testing can be classified broadly into two approaches:

Phenotypic Testing – Measures actual growth inhibition of bacteria in the presence of antibiotics.

Genotypic Testing – Detects specific resistance genes or mutations associated with antimicrobial resistance, often using molecular techniques.

Phenotypic testing remains the gold standard for clinical decision-making because it reflects the actual response of the organism to the drug in vitro. Genotypic testing complements phenotypic methods by providing rapid detection of known resistance determinants.

Standard Methods for Antibiotic Susceptibility Testing

1. Disk Diffusion Method (Kirby-Bauer Test)

Principle

The disk diffusion method assesses bacterial susceptibility by measuring zones of inhibition around antibiotic-impregnated disks placed on agar plates inoculated with the test organism.

Materials and Procedure

• Mueller-Hinton agar plates
• Standardized bacterial inoculum (0.5 McFarland standard)
• Antibiotic-impregnated disks
• Incubator at 35–37°C

Steps:

• Prepare a standardized bacterial suspension.
• Inoculate the agar surface uniformly using a sterile swab.
• Place antibiotic disks on the inoculated plate.
• Incubate for 16–24 hours.
• Measure the diameter of inhibition zones and compare to Clinical and Laboratory Standards Institute (CLSI) or EUCAST breakpoints.

Advantages

• Simple and cost-effective
• Suitable for routine laboratory use
• Can test multiple antibiotics simultaneously

Limitations

• Provides qualitative data (susceptible, intermediate, resistant)
• Less precise for slow-growing or fastidious organisms
• Environmental factors can influence results

2. Broth Dilution Methods

Principle

Broth dilution determines the minimum inhibitory concentration (MIC), the lowest antibiotic concentration that inhibits visible growth of the organism.

Types

• Macrobroth dilution – Uses test tubes with serial dilutions of antibiotics
• Microbroth dilution – Uses 96-well microtiter plates for high-throughput testing

Procedure

• Prepare serial twofold dilutions of antibiotics in broth medium.
• Inoculate each dilution with standardized bacterial suspension.
• Incubate at 35–37°C for 16–20 hours.
• Assess growth visually or using spectrophotometry.

Advantages

• Provides quantitative MIC values
• Can detect intermediate resistance
• Suitable for slow-growing bacteria

Limitations

• Labor-intensive for macrobroth dilution
• Requires careful standardization of inoculum and medium

3. Agar Dilution Method

Principle

Agar dilution involves incorporating antibiotics into agar at defined concentrations, followed by inoculation with bacterial strains. Growth is assessed after incubation.

Procedure

• Prepare agar plates with varying concentrations of antibiotics.
• Spot inoculate bacterial strains onto plates.
• Incubate and examine for growth.

Advantages

• Gold standard for certain organisms like Neisseria gonorrhoeae
• Accurate MIC determination

Limitations

• Labor-intensive and not suitable for routine use
• Requires multiple plates for multiple antibiotics

4. E-test (Gradient Diffusion Method)

Principle

E-test combines features of disk diffusion and MIC determination using a strip with a gradient of antibiotic concentrations. The MIC is read where the elliptical inhibition intersects the strip.

Advantages

• Provides quantitative MIC values
• Easy to interpret and use for fastidious organisms

Limitations

• Costlier than standard disk diffusion
• Requires careful handling to avoid errors

Automated and Semi-Automated Systems

1. VITEK 2 (bioMérieux)

Uses cards containing multiple antibiotics and optical detection to assess bacterial growth.

Provides MIC and categorical interpretation within 6–8 hours.

2. MicroScan WalkAway (Beckman Coulter)

Automated microdilution system suitable for Gram-negative and Gram-positive organisms.

3. Phoenix System (BD)

Integrates identification and susceptibility testing with continuous growth monitoring.

Advantages

• Rapid and reproducible results
• Reduced manual labor
• Integrated identification and susceptibility

Limitations

High cost and maintenance

Limited to antibiotics available in the system

Molecular Methods for Antibiotic Resistance Detection

Polymerase Chain Reaction (PCR)

Detects specific resistance genes such as mecA (MRSA), blaKPC (Klebsiella pneumoniae carbapenemase), vanA/vanB (Enterococcus).

Real-Time PCR and Multiplex PCR

Allow rapid detection of multiple resistance genes simultaneously.

DNA Microarrays and Next-Generation Sequencing

Comprehensive profiling of resistance determinants.

Advantages

• Rapid detection of known resistance genes
• Can detect uncultivable organisms

Limitations

Cannot assess phenotypic susceptibility

Limited to known resistance mechanisms

Requires specialized equipment and expertise

Quality Control in AST

Use of reference strains (e.g., E. coli ATCC 25922, S. aureus ATCC 29213)

Regular validation of media, disks, and reagents

Standardization of inoculum density and incubation conditions

Documentation of deviations and corrective actions

Interpretation of AST Results

• Susceptible (S): Likely to respond to therapy
• Intermediate (I): Response uncertain; may require higher doses or site-specific considerations
• Resistant (R): Likely to fail therapy

Interpretation should follow CLSI or EUCAST breakpoints, which are periodically updated based on pharmacokinetics, pharmacodynamics, and clinical outcomes.

Clinical Applications

1. Guiding Antimicrobial Therapy

Ensures appropriate empiric and targeted therapy

Reduces use of broad-spectrum antibiotics

2. Surveillance of Antimicrobial Resistance

Monitoring local resistance patterns

Informing hospital antibiotic policies and infection control

3. Research and Drug Development

Screening new antibiotics

Evaluating resistance mechanisms

Emerging Technologies in AST

• Microfluidics
• Miniaturized platforms for rapid phenotypic testing using small sample volumes
• Potential for same-day MIC results
• MALDI-TOF Mass Spectrometry
• Can detect certain resistance mechanisms (e.g., carbapenemases)
• Reduces time to identification and susceptibility assessment
• Artificial Intelligence and Predictive Modeling
• Uses phenotypic and genotypic data to predict resistance patterns
• Enhances decision-making in clinical microbiology

Challenges in AST

• Emergence of multidrug-resistant and extensively drug-resistant organisms
• Discrepancies between phenotypic and genotypic results
• Limited availability of testing for fastidious organisms
• Cost and resource constraints in low-income settings

Future Perspectives

Development of rapid, point-of-care AST platforms for early therapy optimization

Integration of molecular and phenotypic methods for comprehensive resistance profiling

Global surveillance networks using standardized AST data to track AMR trends

Personalized antimicrobial therapy guided by AI and precision microbiology

CONCLUSION

Antibiotic susceptibility testing is a cornerstone of modern clinical microbiology and antimicrobial stewardship. Traditional phenotypic methods, including disk diffusion, broth dilution, agar dilution, and E-test, provide reliable guidance for therapy, while automated and molecular approaches enhance speed and precision. Quality control, standardized interpretation, and integration with clinical data are essential for optimal patient outcomes. With the growing threat of antimicrobial resistance, innovation in AST technologies, including rapid diagnostics, microfluidics, and AI-based predictive tools, will play a pivotal role in safeguarding effective antimicrobial therapy and public health.

REFERENCES

1. Smith KP and Kirby JE. The inoculum effect in antimicrobial susceptibility testing. Clin Microbiol Rev. 2022;35(1):e00014-21.

   Indexed at, Google Scholar, Crossref

2. Doern GV. The slow march toward rapid antimicrobial susceptibility testing. Clin Microbiol Newsl. 2021;43(3):23â??28.

   Indexed at, Google Scholar, Crossref

3. Jorgensen JH and Ferraro MJ. Antimicrobial susceptibility testing: A review of general principles and contemporary practices. Clin Infect Dis. 2023;76(5):e1234â??e1245.

   Indexed at, Google Scholar, Crossref

4. van Belkum A, Burnham CAD, Rossen JWA, Mallard F, Rochas O and Dunne WM. Innovative and rapid antimicrobial susceptibility testing systems. Nat Rev Microbiol. 2022;20(5):299â??311.

   Indexed at, Google Scholar, Crossref

5. Bassetti M, Peghin M and Vena A. Antimicrobial resistance in the next decade: Emerging threats and solutions. Lancet Infect Dis. 2024;24(2):e45â??e57

   Indexed at, Google Scholar, Crossref